**Core Concept**
Parkinsonism is a neurological disorder characterized by tremors, rigidity, bradykinesia, and postural instability. The primary goal of pharmacotherapy in Parkinsonism is to increase dopamine levels in the striatum, thereby alleviating symptoms. This can be achieved through dopamine replacement, dopamine agonism, or inhibition of dopamine catabolism.

**Why the Correct Answer is Right**
The correct answer involves a mechanism that increases dopamine levels in the brain. Dopamine replacement therapy with levodopa is the most effective treatment for Parkinsonism. Levodopa is a precursor to dopamine that crosses the blood-brain barrier and is converted to dopamine in the brain. This leads to an increase in dopamine levels in the striatum, thereby alleviating symptoms of Parkinsonism. The enzyme responsible for converting levodopa to dopamine is aromatic L-amino acid decarboxylase (AADC).

**Why Each Wrong Option is Incorrect**
**Option A:** This option might refer to a drug that blocks dopamine receptors, which would worsen Parkinsonism symptoms rather than alleviate them.
**Option B:** This option might refer to a drug that inhibits dopamine reuptake, which would increase dopamine levels but is not the primary mechanism of levodopa.
**Option C:** This option might refer to a drug that inhibits the breakdown of dopamine, but this is not the primary mechanism of levodopa.

**Clinical Pearl / High-Yield Fact**
Levodopa is the most effective treatment for Parkinsonism, but it can cause dyskinesias and motor fluctuations when used long-term. This is because the brain adapts to the constant increase in dopamine levels, leading to a decrease in dopamine receptors.

**Correct Answer: A. Levodopa is a precursor to dopamine that crosses the blood-brain barrier and is converted to dopamine in the brain, thereby alleviating symptoms of Parkinsonism.**